175 related articles for article (PubMed ID: 28464734)
21. Prospective MRI-based imaging study to assess feasibility of proton therapy for post-prostatectomy radiation.
Swisher-McClure S; Yin L; Rosen M; Batra S; Berman AT; Both S; Vapiwala N
Acta Oncol; 2016 Jul; 55(7):828-33. PubMed ID: 27145164
[TBL] [Abstract][Full Text] [Related]
22. Optimizing 3DCT image registration for interfractional changes in carbon-ion prostate radiotherapy.
Hirai R; Mori S; Suyari H; Tsuji H; Ishikawa H
Sci Rep; 2023 May; 13(1):7448. PubMed ID: 37156901
[TBL] [Abstract][Full Text] [Related]
23. Motion mitigation in intensity modulated particle therapy by internal target volumes covering range changes.
Graeff C; Durante M; Bert C
Med Phys; 2012 Oct; 39(10):6004-13. PubMed ID: 23039638
[TBL] [Abstract][Full Text] [Related]
24. Technical Note: Feasibility of MRI-based estimation of water-equivalent path length to detect changes in proton range during treatment courses.
Uh J; Krasin MJ; Hua CH
Med Phys; 2018 Apr; 45(4):1677-1683. PubMed ID: 29464718
[TBL] [Abstract][Full Text] [Related]
25. The influence of inter-fractional anatomy variation on secondary cancer risk estimates following radiotherapy.
Stokkevåg CH; Engeseth GM; Hysing LB; Ytre-Hauge KS; Muren LP
Phys Med; 2017 Oct; 42():271-276. PubMed ID: 28941739
[TBL] [Abstract][Full Text] [Related]
26. Feasibility of MRI-only treatment planning for proton therapy in brain and prostate cancers: Dose calculation accuracy in substitute CT images.
Koivula L; Wee L; Korhonen J
Med Phys; 2016 Aug; 43(8):4634. PubMed ID: 27487880
[TBL] [Abstract][Full Text] [Related]
27. Commissioning an in-room mobile CT for adaptive proton therapy with a compact proton system.
Oliver JA; Zeidan O; Meeks SL; Shah AP; Pukala J; Kelly P; Ramakrishna NR; Willoughby TR
J Appl Clin Med Phys; 2018 May; 19(3):149-158. PubMed ID: 29682879
[TBL] [Abstract][Full Text] [Related]
28. Deformable image registration for contour propagation from CT to cone-beam CT scans in radiotherapy of prostate cancer.
Thor M; Petersen JB; Bentzen L; Høyer M; Muren LP
Acta Oncol; 2011 Aug; 50(6):918-25. PubMed ID: 21767192
[TBL] [Abstract][Full Text] [Related]
29. Impact of intrafraction and residual interfraction effect on prostate proton pencil beam scanning.
Tang S; Deville C; Tochner Z; Wang KK; McDonough J; Vapiwala N; Both S
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1186-94. PubMed ID: 25442043
[TBL] [Abstract][Full Text] [Related]
30. Feasibility of MR-only proton dose calculations for prostate cancer radiotherapy using a commercial pseudo-CT generation method.
Maspero M; van den Berg CAT; Landry G; Belka C; Parodi K; Seevinck PR; Raaymakers BW; Kurz C
Phys Med Biol; 2017 Nov; 62(24):9159-9176. PubMed ID: 29076458
[TBL] [Abstract][Full Text] [Related]
31. Commissioning of a proton gantry equipped with dual x-ray imagers and a robotic patient positioner, and evaluation of the accuracy of single-beam image registration for this system.
Wang N; Ghebremedhin A; Patyal B
Med Phys; 2015 Jun; 42(6):2979-91. PubMed ID: 26127051
[TBL] [Abstract][Full Text] [Related]
32. Monte Carlo study on the sensitivity of prompt gamma imaging to proton range variations due to interfractional changes in prostate cancer patients.
Schmid S; Landry G; Thieke C; Verhaegen F; Ganswindt U; Belka C; Parodi K; Dedes G
Phys Med Biol; 2015 Dec; 60(24):9329-47. PubMed ID: 26581022
[TBL] [Abstract][Full Text] [Related]
33. Hydrogel rectum-prostate spacers mitigate the uncertainties in proton relative biological effectiveness associated with anterior-oblique beams.
Underwood TS; Voog JC; Moteabbed M; Tang S; Soffen E; Cahlon O; Lu HM; Zietman AL; Efstathiou JA; Paganetti H
Acta Oncol; 2017 Apr; 56(4):575-581. PubMed ID: 28075206
[TBL] [Abstract][Full Text] [Related]
34. Pelvic lymph node displacement in high-risk prostate cancer patients treated with image guided intensity modulated radiation therapy with 2 independent target volumes.
Lecavalier-Barsoum M; Souhami L; Cury F; Duclos M; Ruo R; Faria S
Pract Radiat Oncol; 2015; 5(6):406-10. PubMed ID: 26127006
[TBL] [Abstract][Full Text] [Related]
35. LOW DOSE BATH FROM IMPT VS. IMXT FOR THE PELVIC AREA WHEN TREATING ADVANCED PROSTATE CANCER.
Navrátil M; Vondráček V; Andrlík M; Kubeš J; Rosina J; Grebenyuk A
Radiat Prot Dosimetry; 2019 Dec; 186(2-3):377-380. PubMed ID: 31711189
[TBL] [Abstract][Full Text] [Related]
36. Validation of an in-vivo proton beam range check method in an anthropomorphic pelvic phantom using dose measurements.
Bentefour el H; Tang S; Cascio EW; Testa M; Samuel D; Prieels D; Gottschalk B; Lu HM
Med Phys; 2015 Apr; 42(4):1936-47. PubMed ID: 25832084
[TBL] [Abstract][Full Text] [Related]
37. In vivo verification of proton beam path by using post-treatment PET/CT imaging.
Hsi WC; Indelicato DJ; Vargas C; Duvvuri S; Li Z; Palta J
Med Phys; 2009 Sep; 36(9):4136-46. PubMed ID: 19810487
[TBL] [Abstract][Full Text] [Related]
38. Helical tomotherapy vs. intensity-modulated proton therapy for whole pelvis irradiation in high-risk prostate cancer patients: dosimetric, normal tissue complication probability, and generalized equivalent uniform dose analysis.
Widesott L; Pierelli A; Fiorino C; Lomax AJ; Amichetti M; Cozzarini C; Soukup M; Schneider R; Hug E; Di Muzio N; Calandrino R; Schwarz M
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1589-600. PubMed ID: 21167651
[TBL] [Abstract][Full Text] [Related]
39. Offline multiple adaptive planning strategy for concurrent irradiation of the prostate and pelvic lymph nodes.
Qi P; Pouliot J; Roach M; Xia P
Med Phys; 2014 Feb; 41(2):021704. PubMed ID: 24506595
[TBL] [Abstract][Full Text] [Related]
40. Magnetic resonance-only simulation and dose calculation in external beam radiation therapy: a feasibility study for pelvic cancers.
Kemppainen R; Suilamo S; Tuokkola T; Lindholm P; Deppe MH; Keyriläinen J
Acta Oncol; 2017 Jun; 56(6):792-798. PubMed ID: 28270011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
